Published in Am J Med on March 01, 2010
Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol (2009) 6.51
The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur J Immunol (2003) 2.29
Diagnosis and management of primary chylous ascites. J Vasc Surg (2006) 1.72
Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients. Eur J Immunol (2004) 1.53
Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone-sensitive early-stage breast cancer: a meta-analysis. Lancet Oncol (2006) 1.44
HER2/neu oncoprotein overexpression in epithelial ovarian cancer: evaluation of its prevalence and prognostic significance. Clinical study. Oncology (2005) 1.41
A case of transposition of the great arteries in a female infant of a HIV-1-infected woman. Potential teratogenic effects of antiretroviral drugs. Intern Emerg Med (2006) 1.39
Migraine during systemic lupus erythematosus: findings from brain single photon emission computed tomography. J Rheumatol (2006) 1.39
Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol (2003) 1.36
Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function. Hum Immunol (2004) 1.32
Emerging biological drugs: a new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events. Autoimmun Rev (2011) 1.26
Current views on diagnostic approach and treatment of lymphedema. Am J Med (2012) 1.21
Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans. Blood (2009) 1.19
Congenital pulmonary lymphangiectasia. Orphanet J Rare Dis (2006) 1.18
The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases. Intern Emerg Med (2011) 1.15
Impaired response to influenza vaccine associated with persistent memory B cell depletion in non-Hodgkin's lymphoma patients treated with rituximab-containing regimens. J Immunol (2011) 1.11
Endothelial dysfunction in rheumatic autoimmune diseases. Atherosclerosis (2012) 1.10
Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction. Blood (2002) 1.08
Evolution of chylous fistula management after neck dissection. Curr Opin Otolaryngol Head Neck Surg (2013) 1.06
Infection risk associated with anti-TNF-α agents: a review. Expert Opin Drug Saf (2015) 1.06
Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial. J Natl Cancer Inst (2011) 1.05
Microsurgery for lymphedema: clinical research and long-term results. Microsurgery (2010) 1.05
Etiology of nonimmune hydrops fetalis: a systematic review. Am J Med Genet A (2009) 1.00
Leptin as a uremic toxin interferes with neutrophil chemotaxis. J Am Soc Nephrol (2004) 1.00
Migration of V delta 1 and V delta 2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat. Blood (2003) 1.00
Prognostic value of stromal and epithelial periostin expression in human prostate cancer: correlation with clinical pathological features and the risk of biochemical relapse or death. BMC Cancer (2012) 0.98
Transforming growth factor-beta1 in supernatants from stored red blood cells inhibits neutrophil locomotion. Blood (2003) 0.96
Pemetrexed for the treatment of non-small cell lung cancer. Expert Opin Pharmacother (2013) 0.96
Next generation sequencing in non-small cell lung cancer: new avenues toward the personalized medicine. Curr Drug Targets (2015) 0.95
Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current views upon safety and immunogenicity. Autoimmun Rev (2013) 0.94
Differential expression of nuclear lamins in normal and cancerous prostate tissues. Oncol Rep (2006) 0.93
Hennekam syndrome presenting as nonimmune hydrops fetalis, congenital chylothorax, and congenital pulmonary lymphangiectasia. Am J Med Genet A (2003) 0.92
The lymphatics in the pathophysiology of thoracic and abdominal surgical pathology: immunological consequences and the unexpected role of microsurgery. Microsurgery (2007) 0.92
The medical oncologist's role in palliative care: AIOM's position. Tumori (2010) 0.91
The application of atmospheric pressure matrix-assisted laser desorption/ionization to the analysis of long-term cryopreserved serum peptidome. Anal Biochem (2011) 0.90
Afatinib resistance in non-small cell lung cancer involves the PI3K/AKT and MAPK/ERK signalling pathways and epithelial-to-mesenchymal transition. Target Oncol (2014) 0.90
Low expression of inhibitory natural killer receptors in CD8 cytotoxic T lymphocytes in long-term non-progressor HIV-1-infected patients. AIDS (2003) 0.90
Pharmacogenetics of etanercept: role of TNF-α gene polymorphisms in improving its efficacy. Expert Opin Drug Metab Toxicol (2014) 0.89
Emerging biologic drugs for the treatment of rheumatoid arthritis. Autoimmun Rev (2005) 0.89
Lymphatic microsurgery to treat lymphedema: techniques and indications for better results. Ann Plast Surg (2013) 0.88
Complement C3f serum levels may predict breast cancer risk in women with gross cystic disease of the breast. J Proteomics (2013) 0.88
Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. Ann Surg Oncol (2009) 0.87
Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia: a case-control study. Am J Med Genet B Neuropsychiatr Genet (2004) 0.87
Microsurgery for treatment of peripheral lymphedema: long-term outcome and future perspectives. Microsurgery (2007) 0.87
Effect of clotting factors concentrates on lymphocyte and neutrophil function in vitro. Thromb Haemost (2003) 0.86
Clinical features and molecular modelling of novel MPZ mutations in demyelinating and axonal neuropathies. Eur J Hum Genet (2009) 0.86
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer. Cancer Immunol Immunother (2013) 0.86
The spectrum of GNE mutations: allelic heterogeneity for a common phenotype. Neurol Sci (2010) 0.85
Differential proteomic analysis of nuclear matrix in muscle-invasive bladder cancer: potential to improve diagnosis and prognosis. Cell Oncol (2008) 0.85
Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study). Autoimmun Rev (2008) 0.85
Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report. Ann Allergy Asthma Immunol (2005) 0.85
Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer. Future Oncol (2013) 0.85
Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults. Hum Vaccin Immunother (2012) 0.84
Microsurgical techniques for lymphedema treatment: derivative lymphatic-venous microsurgery. World J Surg (2004) 0.84
Diagnostic assessment and therapeutic approach for immunodeficiency due to chylous dysplasia: A case report. Microsurgery (2010) 0.84
Potential use of TNF-α inhibitors in systemic sclerosis. Immunotherapy (2014) 0.83
HSPB1 and HSPB8 in inherited neuropathies: study of an Italian cohort of dHMN and CMT2 patients. J Peripher Nerv Syst (2011) 0.83
Prognostic value of cell cycle regulatory proteins in muscle-infiltrating bladder cancer. J Cancer Res Clin Oncol (2006) 0.83
Update upon efficacy and safety of TNF-α inhibitors. Expert Opin Drug Saf (2011) 0.83
Defective expression and function of the leukocyte associated Ig-like receptor 1 in B lymphocytes from systemic lupus erythematosus patients. PLoS One (2012) 0.83
Current therapies for the treatment of systemic sclerosis-related pulmonary arterial hypertension: efficacy and safety. Expert Opin Drug Saf (2014) 0.83
Interorgan exchange of aminothiols in humans. Am J Physiol Endocrinol Metab (2002) 0.83
Free radicals and endothelial dysfunction: potential positive effects of TNF-α inhibitors. Redox Rep (2013) 0.82
Surgical prevention of arm lymphedema after breast cancer treatment. Ann Surg Oncol (2011) 0.82
Nuclear matrix protein expression in prostate cancer: possible prognostic and diagnostic applications. Anticancer Res (2005) 0.82
Germline mutations in the von Hippel-Lindau gene in Italian patients. Eur J Med Genet (2009) 0.82
Prognostic value of nuclear matrix protein expression in localized prostate cancer. J Cancer Res Clin Oncol (2012) 0.81
Randomized phase III trial of adjuvant epirubicin followed by cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) versus CMF followed by epirubicin in patients with node-negative or 1-3 node-positive rapidly proliferating breast cancer. Breast Cancer Res Treat (2010) 0.81
Single skull metastasis 15 years after primary treatment of prostate cancer and with undetectable PSA levels: a case report and review of the literature. Tumori (2013) 0.81
Lymphatic complications in surgery: possibility of prevention and therapeutic options. Updates Surg (2012) 0.81
Primary bladder angiosarcoma with no apparent previous exposure to carcinogens: a case report. Anal Quant Cytopathol Histpathol (2013) 0.81
Whole body bone scintigraphy in tenofovir-related osteomalacia: a case report. J Med Case Rep (2009) 0.81
Effects of uremia and inflammation on growth hormone resistance in patients with chronic kidney diseases. Kidney Int (2008) 0.80
Effects of TNF-α inhibitors upon the mechanisms of action of VEGF. Immunotherapy (2013) 0.80